Mechanisms for suppressing NADPH oxidase in the vascular wall
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Oxidative stress underlies many forms of vascular disease as well as tissue injury following ischemia and reperfusion. The major source of oxidative stress in the artery wall is an NADPH oxidase. This enzyme complex as expressed in vascular cells differs from that in phagocytic leucocytes both in biochemical structure and functions. The crucial flavin-containing catalytic subunits, Nox1 and Nox4, are not found in leucocytes, but are highly expressed in vascular cells and upregulated with vascular remodeling, such as that found in hypertension and atherosclerosis. The difference in catalytic subunits offers the opportunity to develop "vascular specific" NADPH oxidase inhibitors that do not compromise the essential physiological signaling and phagocytic functions carried out by reactive oxygen and nitrogen species. Nitric oxide and targeted inhibitors of NADPH oxidase that block the source of oxidative stress in the vasculature are more likely to prevent the deterioration of vascular function that leads to stroke and heart attack, than are conventional antioxidants. The roles of Nox isoforms in other inflammatory conditions are yet to be explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839 · cited 3×
“Second, the gp91phox catalytic subunit to which NADPH and oxygen bind is substituted by Nox1 or Nox4 homologues, particularly in smooth muscle (Lassegue et al. 2001, Bengtsson et al. 2003, Ellmark et al. 2004).”
BackgroundThe vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687
Recent advances torwards understanding redox mechanisms in the activation of nuclear factor κb
Janssen-Heininger, Y. M. W., Poynter, M. E., & Baeuerle, P. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00218-5 · Cited by 666
Park, H. S., Jung, H. Y., Park, E. Y., Kim, J., Lee, W. J., & Bae, Y. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3589 · Cited by 635 · cited 1×
“…(LPS, an integral component of the outer membrane of gram-negative bacteria) can activate NADPH oxidase is through binding to the Toll-like receptor (TLR4), the cytoplasmic tail of which was recently found to interact with the carboxy terminal of Nox4 in HEK293 kidney cells (Park et al. 2004).”
BackgroundGörlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F., & Busse, R. (2000) · Circulation Research · doi:10.1161/01.res.87.1.26 · Cited by 598 · cited 2×
“Third, whilst the Nox homologue and the membrane-bound p22phox subunit are essential to maintain a stable unit capable of supporting electron transfer for superoxide generation (Ambasta et al. 2004), it remains unclear what role the cytosolic components play in the vascular NADPH oxidase: this latter point has implica…”
BackgroundAmbasta, R. K., Kumar, P., Griendling, K. K., Schmidt, H. H. H. W., Busse, R., & Brandes, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406486200 · Cited by 541
Nox4 as the Major Catalytic Component of an Endothelial NAD(P)H Oxidase
Ago, T., Kitazono, T., Ooboshi, H., Iyama, T., Han, Y. H., Takada, J., Wakisaka, M., Ibayashi, S., Utsumi, H., & Iida, M. (2004) · Circulation · doi:10.1161/01.cir.0000105680.92873.70 · Cited by 497
Kirk, E. A., Dinauer, M. C., Rosen, H., Chait, A., Heinecke, J. W., & LeBoeuf, R. C. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1529 · Cited by 171
Research works printed but not linked: 44
- Al-Mehdi AB, 1998, Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+, Circ Res, 83, 730, 10.1161/01.RES.83.7.730 · DOI · Paper page
- Babior BM, 1999, NADPH oxidase: an update, Blood, 93, 1464, 10.1182/blood.V93.5.1464 · DOI · Paper page
- Barry-Lane PA, 2001, p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice, J Clin Invest, 108, 1513, 10.1172/JCI200111927 · DOI · Paper page
- Baykal Y, 2003, Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress, J Hypertens, 21, 1207, 10.1097/00004872-200306000-00022 · DOI
- Beckman JS, 1990, Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc Natl Acad Sci USA, 87, 1620, 10.1073/pnas.87.4.1620 · DOI · Paper page
- Bengtsson SH, 2003, Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology, Clin Exp Pharmacol Physiol, 30, 849, 10.1046/j.1440-1681.2003.03929.x · DOI · Paper page
- Boota A, 2000, Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle, Am J Physiol Lung Cell Mol Physiol, 278, L329, 10.1152/ajplung.2000.278.2.L329 · DOI
- Cayatte AJ, 2001, S17834, a new inhibitor of cell adhesion and atherosclerosis that targets nadph oxidase, Arterioscler Thromb Vasc Biol, 21, 1577, 10.1161/hq1001.096723 · DOI · Paper page
- Chen Z, 2004, Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury, Proc Natl Acad Sci USA, 101, 13014, 10.1073/pnas.0405389101 · DOI · Paper page
- Cheng G, 2001, Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5, Gene, 269, 131, 10.1016/S0378-1119(01)00449-8 · DOI · Paper page
- Dodd OJ, 2000, Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury, Am J Physiol Heart Circ Physiol, 279, H303, 10.1152/ajpheart.2000.279.1.H303 · DOI · Paper page
- Drummond GR, 2003, Importance of the Nox4 subunit in NADPH oxidase-derived superoxide production in vascular smooth muscle cells, Circulation, 108, IV
- Dusting GJ, 1999, Endothelial dysfunction associated with cardiovascular disease and transplantation, 410
- Dusting GJ, 1998, Nitric oxide in atherosclerosis: vascular protector or villain?, Clin Exp Pharmacol Physiol, 25, S34, 10.1111/j.1440-1681.1998.tb02298.x · DOI · Paper page
- Gorzalczany Y, 2000, Targeting of Rac1 to the phagocyte membrane is sufficient for the induction of NADPH oxidase assembly, J Biol Chem, 275, 40073, 10.1074/jbc.M006013200 · DOI · Paper page
- Griendling KK, 2000, NAD(P)H oxidase: role in cardiovascular biology and disease, Circ Res, 86, 494, 10.1161/01.RES.86.5.494 · DOI · Paper page
- Guzik TJ, 2000, Vascular superoxide production by NAD(P)H Oxidase: association with endothelial dysfunction and clinical risk factors, Circ Res, 86, E85, 10.1161/01.RES.86.9.e85 · DOI · Paper page
- Hwang J, 2003, Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation, Circ Res, 93, 1225, 10.1161/01.RES.0000104087.29395.66 · DOI · Paper page
- Jacobson GM, 2003, Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery, Circ Res, 92, 637, 10.1161/01.RES.0000063423.94645.8A · DOI · Paper page
- Jiang F, 2003, Natural phenolic compounds as cardiovascular therapeutics: potential role of their antiinflammatory effects, Curr Vasc Pharmacol, 1, 135, 10.2174/1570161033476736 · DOI
- Jiang F, 2002, Inhibition of ge-ranylgeranylation of small G protein Rac suppresses NADPH oxidase activity in rat aortic smooth muscle cells, Pharmacologist, 44, A90
- Kunsch C, 1999, Oxidative stress as a regulator of gene expression in the vasculature, Circ Res, 85, 753, 10.1161/01.RES.85.8.753 · DOI · Paper page
- Maack C, 2003, Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment, Circulation, 108, 1567, 10.1161/01.CIR.0000091084.46500.BB · DOI · Paper page
- Munzel T, 1999, Role for NADPH/NADH oxidase in the modulation of vascular tone, Ann NY Acad Sci, 874, 386, 10.1111/j.1749-6632.1999.tb09253.x · DOI · Paper page
- O'Donnell BV, 1993, Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase, Biochem J, 290, 41, 10.1042/bj2900041 · DOI · Paper page
- Paravicini TM, 2002, Increased NADPH oxidase activity, gp91phox expression, and endothelium- dependent vasorelaxation during neointima formation in rabbits, Circ Res, 91, 54, 10.1161/01.RES.0000024106.81401.95 · DOI · Paper page
- Rey FE, 2001, Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice, Circ Res, 89, 408, 10.1161/hh1701.096037 · DOI · Paper page
- Seshiah PN, 2002, Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators, Circ Res, 91, 406, 10.1161/01.RES.0000033523.08033.16 · DOI · Paper page
- Shi J, 1996, PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox, Proc Natl Acad Sci USA, 93, 6014, 10.1073/pnas.93.12.6014 · DOI · Paper page
- Souza HP, 2000, Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity, Free Radic Biol Med, 28, 1232, 10.1016/S0891-5849(00)00240-9 · DOI
- Steinberg D, 2002, Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime, Nat Med, 8, 1211, 10.1038/nm1102-1211 · DOI · Paper page
- Stolk J, 1994, Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol, Am J Respir Cell Mol Biol, 11, 95, 10.1165/ajrcmb.11.1.8018341 · DOI · Paper page
- Stuehr DJ, 1991, Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyl-eneiodonium and its analogs, Faseb J, 5, 98, 10.1096/fasebj.5.1.1703974 · DOI · Paper page
- Thum T, 2004, Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism?, Circ Res, 94, e1, 10.1161/01.RES.0000110081.03480.E9 · DOI
- Touyz RM, 2003, c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells, Arterioscler Thromb Vasc Biol, 23, 981, 10.1161/01.ATV.0000069236.27911.68 · DOI · Paper page
- Ushio-Fukai M, 2002, Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis, Circ Res, 91, 1160, 10.1161/01.RES.0000046227.65158.F8 · DOI · Paper page
- Wagner AH, 2000, Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation, Arterioscler Thromb Vasc Biol, 20, 61, 10.1161/01.ATV.20.1.61 · DOI · Paper page
- Warnholtz A, 1999, Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system, Circulation, 99, 2027, 10.1161/01.CIR.99.15.2027 · DOI · Paper page
- Wattanapitayakul SK, 2001, Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications, Pharmacol Ther, 89, 187, 10.1016/S0163-7258(00)00114-5 · DOI · Paper page
- West N, 2001, Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase, Arterioscler Thromb Vasc Biol, 21, 189, 10.1161/01.ATV.21.2.189 · DOI
- White CR, 1994, Superoxide and peroxynitrite in atherosclerosis, Proc Natl Acad Sci USA, 91, 1044, 10.1073/pnas.91.3.1044 · DOI · Paper page
- Yang S, 2001, A new superoxide-generating oxidase in murine osteoclasts, J Biol Chem, 276, 5452, 10.1074/jbc.M001004200 · DOI · Paper page
- Zalba G, 2000, Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats, Hypertension, 35, 1055, 10.1161/01.HYP.35.5.1055 · DOI · Paper page
- Zicha J, 2001, Relative deficiency of nitric oxide-dependent vasodilation in salt- hypertensive Dahl rats: the possible role of superoxide anions, J Hypertens, 19, 247, 10.1097/00004872-200102000-00011 · DOI
Cited by
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
Lambeth, J. D. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.027 · Cited by 679
Mammalian Heme Peroxidases: From Molecular Mechanisms to Health Implications
Davies, M. J., Hawkins, C. L., Pattison, D. I., & Rees, M. D. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1927 · Cited by 560
Myeloperoxidase-derived oxidation: Mechanisms of biological damage and its prevention
Davies, M. J. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-006fr · Cited by 412
Sheppard, F. R., Kelher, M. R., Moore, E. E., McLaughlin, N. J. D., Banerjee, A., & Silliman, C. C. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0804442 · Cited by 372
Role of shear stress and stretch in vascular mechanobiology
Lu, D., & Kassab, G. S. (2011) · Journal of The Royal Society Interface · doi:10.1098/rsif.2011.0177 · Cited by 328
Metadata
- Authors
- Dusting, G. J., Selemidis, S., & Jiang, F.
- Venue
- Memórias do Instituto Oswaldo Cruz
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2005-03
- Volume
- 100
- Issue
- suppl 1
- Pages
- 97-103
- ISSN
- 0074-0276 (ISSN-L)
- OpenAlex
- W2152467696
- Cited by
- 62
- References
- 9
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms for suppressing NADPH oxidase in the vascular wall. https://app.cochat.ai/papers/10.1590/s0074-02762005000900016
- The paper
- Dusting, G. J., Selemidis, S., & Jiang, F. (2005). Mechanisms for suppressing NADPH oxidase in the vascular wall. Memórias do Instituto Oswaldo Cruz. https://doi.org/10.1590/s0074-02762005000900016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.